These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 7654282

  • 1. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
    Drug Ther Bull; 1994 Feb 17; 32(2):12-5. PubMed ID: 7654282
    [Abstract] [Full Text] [Related]

  • 2. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC, Griffith L, Guyatt GH, Opravil M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun 01; 15(2):104-14. PubMed ID: 9241108
    [Abstract] [Full Text] [Related]

  • 3. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD, Rimland D.
    AIDS; 1999 May 28; 13(8):991-2. PubMed ID: 10371182
    [No Abstract] [Full Text] [Related]

  • 4. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E.
    AIDS; 1994 Feb 28; 8(2):272-4. PubMed ID: 8043236
    [No Abstract] [Full Text] [Related]

  • 5. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD, Easterbrook PJ.
    J Antimicrob Chemother; 1997 Sep 28; 40(3):315-8. PubMed ID: 9338481
    [No Abstract] [Full Text] [Related]

  • 6. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS, Wara DW, Duliege AM.
    J Pediatr; 1993 Jan 28; 122(1):163-4. PubMed ID: 8419606
    [No Abstract] [Full Text] [Related]

  • 7. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.
    Schuval SJ, Bonagura VR.
    Arch Pediatr Adolesc Med; 1994 Aug 28; 148(8):876-9. PubMed ID: 8044270
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 Aug 28; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 9. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ, Hoover DR, Peng Y, Phair JP, Visscher B, Kingsley LA, Schrager LK.
    JAMA; 1995 Apr 19; 273(15):1197-202. PubMed ID: 7707627
    [Abstract] [Full Text] [Related]

  • 10. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection.
    J Acquir Immune Defic Syndr (1988); 1993 Jan 19; 6(1):46-55. PubMed ID: 8417174
    [No Abstract] [Full Text] [Related]

  • 11. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
    Smego RA, Nagar S, Maloba B, Popara M.
    Arch Intern Med; 2001 Jun 25; 161(12):1529-33. PubMed ID: 11427101
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.
    N Engl J Med; 1995 Mar 16; 332(11):693-9. PubMed ID: 7854375
    [Abstract] [Full Text] [Related]

  • 13. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD, Bogner JR.
    Internist (Berl); 1995 Dec 16; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract] [Full Text] [Related]

  • 14. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, Benowitz N, Wofsy CB.
    N Engl J Med; 1990 Sep 20; 323(12):776-82. PubMed ID: 2392131
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS, Yang JJ, Lee NY, Chen GJ, Ko WC, Sun HY, Hung CC.
    Expert Rev Anti Infect Ther; 2017 Sep 20; 15(9):873-892. PubMed ID: 28782390
    [Abstract] [Full Text] [Related]

  • 16. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients.
    Mayer HB, Rose DN, Cohen S, Gurtman AC, Cheung TW, Szabo S.
    AIDS; 1993 Dec 20; 7(12):1687-9. PubMed ID: 8286088
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR.
    Ann Intern Med; 1996 May 01; 124(9):792-802. PubMed ID: 8610948
    [Abstract] [Full Text] [Related]

  • 18. Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
    Wilkinson SB.
    Am J Med; 1995 Apr 01; 98(4):422-3. PubMed ID: 7709963
    [No Abstract] [Full Text] [Related]

  • 19. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 20. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
    Connelly RT, Lourwood DL.
    Pharmacotherapy; 1994 May 27; 14(4):424-9. PubMed ID: 7937279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.